{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:04Z","timestamp":1786985404594,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jprasurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bjps.2023.04.036","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T12:29:44Z","timestamp":1681820984000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ensuring patient centeredness in upper extremity lymphedema research: Identifying patient-prioritized agenda and preferences"],"prefix":"10.1016","volume":"83","author":[{"given":"Manraj N.","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie D.","family":"Cornacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siba","family":"Haykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hircock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Mehrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalibor","family":"Vasilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Pusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bjps.2023.04.036_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12282-021-01274-5","article-title":"Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes","volume":"28","author":"Gasteratos","year":"2021","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000004045","article-title":"Evidence mapping of the treatments for breast cancer-related lymphedema","volume":"10","author":"Al-Sakkaf","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10549-016-3716-0","article-title":"A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer","volume":"156","author":"Dionyssiou","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bjps.2023.04.036_bib4","unstructured":"Comment on the proposed new and revised PCORI methodology standards. 2: Standards Associated with Patient-Centeredness: Patient-Centered Outcomes Research Institute; 2016. [cited 2022 February 15]. Available from: \u3008https:\/\/www.pcori.org\/about\/provide-input\/past-opportunities-provide-input\/comment-proposed-new-and-revised-pcori-methodology-standards-2016\/methodology-standards\/page-2\u3009."},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib5","first-page":"290","article-title":"Tokenism in patient engagement","volume":"34","author":"Hahn","year":"2017","journal-title":"Fam Pract"},{"issue":"8","key":"10.1016\/j.bjps.2023.04.036_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/bmjqs-2015-004839","article-title":"From tokenism to empowerment: progressing patient and public involvement in healthcare improvement","volume":"25","author":"Ocloo","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.bjps.2023.04.036_bib7","series-title":"Focus groups: a practical guide for applied research","author":"Krueger","year":"2014"},{"issue":"9","key":"10.1016\/j.bjps.2023.04.036_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jama.293.9.1089","article-title":"Impact of participant and physician intervention preferences on randomized trials: a systematic review","volume":"293","author":"King","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bjps.2023.04.036_bib9","doi-asserted-by":"crossref","first-page":"e8668","DOI":"10.1136\/bmj.e8668","article-title":"Differential dropout and bias in randomised controlled trials: when it matters and when it may not","volume":"346","author":"Bell","year":"2013","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.bjps.2023.04.036_bib10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/sim.8119","article-title":"Optimising the two-stage randomised trial design when some participants are indifferent in their treatment preferences","volume":"38","author":"Walter","year":"2019","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.bjps.2023.04.036_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1525\/jer.2010.5.2.81","article-title":"Effects of participant preferences in unblinded randomized controlled trials","volume":"5","author":"Floyd","year":"2010","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib12","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1038\/s41598-021-89055-0","article-title":"Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors","volume":"11","author":"Togawa","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bjps.2023.04.036_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamasurg.2020.0230","article-title":"Quality-of-life outcomes in surgical vs nonsurgical treatment of breast cancer-related lymphedema: a systematic review","volume":"155","author":"Fish","year":"2020","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","article-title":"The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment","volume":"7","author":"J\u00f8rgensen","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"10.1016\/j.bjps.2023.04.036_bib15","first-page":"665","article-title":"Upper limb function and quality of life in breast cancer related lymphedema: a cross-sectional study","volume":"49","author":"Pinto","year":"2013","journal-title":"Eur J Phys Rehabil Med"},{"issue":"4","key":"10.1016\/j.bjps.2023.04.036_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/00015458.2014.11681019","article-title":"The quality of life in long-term breast cancer survivors with breast cancer related lymphedema","volume":"114","author":"Lopez Penha","year":"2014","journal-title":"Acta Chir Belg"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5737\/1181912x163165171","article-title":"Living with lymphedema: a qualitative study of women's perspectives on prevention and management following breast cancer-related treatment","volume":"16","author":"Greenslade","year":"2006","journal-title":"Can Oncol Nurs J"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/082585970802400302","article-title":"The psychosocial effects of cancer-related lymphedema","volume":"24","author":"Towers","year":"2008","journal-title":"J Palliat Care"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.soncn.2012.11.007","article-title":"Psychosocial impact of living with cancer-related lymphedema","volume":"29","author":"Fu","year":"2013","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.bjps.2023.04.036_bib20","article-title":"\"I never heard anything about it\": knowledge and psychosocial needs of Latina breast cancer survivors with lymphedema","volume":"17","author":"Buki","year":"2021","journal-title":"Women\u2019s Health"},{"issue":"6","key":"10.1016\/j.bjps.2023.04.036_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.12968\/ijpn.2004.10.6.13270","article-title":"A phenomenological study of the lived experiences of people with lymphoedema","volume":"10","author":"Williams","year":"2004","journal-title":"Int J Palliat Nurs"},{"issue":"4","key":"10.1016\/j.bjps.2023.04.036_bib22","doi-asserted-by":"crossref","DOI":"10.1188\/14.ONF.E220-E237","article-title":"Living with breast cancer-related lymphedema: a synthesis of qualitative research","volume":"41","author":"Burckhardt","year":"2014","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.bjps.2023.04.036_bib23","first-page":"7","article-title":"The information needs of patients with therapy-related lymphoedema","volume":"8","author":"Honnor","year":"2009","journal-title":"Cancer Nurs Pract"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1245\/s10434-020-09346-0","article-title":"Patient-reported outcome measures in lymphedema: a systematic review and COSMIN analysis","volume":"28","author":"Beelen","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1245\/s10434-020-09348-y","article-title":"Patient-reported outcome measures in lymphedema: a systematic review and COSMIN analysis","volume":"28","author":"Schaverien","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030565","article-title":"Systematic review of patient-reported outcomes following surgical treatment of lymphedema","volume":"12","author":"Coriddi","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11764-012-0247-5","article-title":"Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes","volume":"7","author":"Pusic","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10.1016\/j.bjps.2023.04.036_bib28","first-page":"26","article-title":"A quality of life measure for limb lymphoedema (LYMQOL)","volume":"5","author":"Keeley","year":"2010","journal-title":"J Lymphoedema"},{"key":"10.1016\/j.bjps.2023.04.036_bib29","first-page":"S266","article-title":"Quality of life scale in upper limb lymphoedema\u2013a validation study","volume":"Suppl. 33","author":"Launois","year":"2000","journal-title":"Lymphology"},{"issue":"6","key":"10.1016\/j.bjps.2023.04.036_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2522\/ptj.20100087","article-title":"Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): reliability and validity","volume":"91","author":"Devoogdt","year":"2011","journal-title":"Phys Ther"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/lrb.2018.0025","article-title":"Revision of the lymphedema functioning, disability and health questionnaire for upper limb lymphedema (Lymph-ICF-UL): reliability and validity","volume":"17","author":"De Vrieze","year":"2019","journal-title":"Lymphat Res Biol"},{"issue":"10","key":"10.1016\/j.bjps.2023.04.036_bib32","first-page":"3103","article-title":"Development and validation of the lymphedema symptom and intensity survey-arm","volume":"23","author":"Ridner","year":"2015","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.bjps.2023.04.036_bib33","first-page":"128","article-title":"Validation of the lymphedema life impact scale (LLIS): a condition-specific measurement tool for persons with lymphedema","volume":"48","author":"Weiss","year":"2015","journal-title":"Lymphology"},{"issue":"2","key":"10.1016\/j.bjps.2023.04.036_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11136-014-0783-8","article-title":"Lymphedema quality of life inventory (LyQLI)-development and investigation of validity and reliability","volume":"24","author":"Klern\u00e4s","year":"2015","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.bjps.2023.04.036_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.bjps.2023.04.036_bib36","unstructured":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes, 4; 2006, p. 79. Epub 2006\/10\/13. DOI: \u300810.1186\/1477-7525-4-79\u3009. PubMed PMID: 17034633; PubMed Central PMCID: PMCPMC1629006."},{"issue":"9","key":"10.1016\/j.bjps.2023.04.036_bib37","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1245\/s10434-021-09887-y","article-title":"Development and psychometric validation of a patient-reported outcome measure for arm lymphedema: the LYMPH-Q upper extremity module","volume":"28","author":"Klassen","year":"2021","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681523002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681523002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:51:43Z","timestamp":1761684703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1748681523002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S1748681523002000"],"URL":"https:\/\/doi.org\/10.1016\/j.bjps.2023.04.036","relation":{},"ISSN":["1748-6815"],"issn-type":[{"value":"1748-6815","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ensuring patient centeredness in upper extremity lymphedema research: Identifying patient-prioritized agenda and preferences","name":"articletitle","label":"Article Title"},{"value":"Journal of Plastic, Reconstructive & Aesthetic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjps.2023.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}